Lista de obras - Giusi Barra - Dominio Público Uruguay

A New Bioassay Platform Design for the Discovery of Small Molecules with Anticancer Immunotherapeutic Activity

artículo científico publicado en 2020

A new marine-derived sulfoglycolipid triggers dendritic cell activation and immune adjuvant response.

artículo científico publicado en 2017

AIRE polymorphism, melanoma antigen-specific T cell immunity, and susceptibility to melanoma.

artículo científico publicado en 2016

Activity and molecular targets of pioglitazone via blockade of proliferation, invasiveness and bioenergetics in human NSCLC

artículo científico publicado en 2019

Antitumor activity of dual blockade of PD-L1 and MEK in NSCLC patients derived three-dimensional spheroid cultures.

artículo científico publicado en 2019

Chitinase 3-like-1 is produced by human Th17 cells and correlates with the level of inflammation in juvenile idiopathic arthritis patients

artículo científico publicado en 2016

Correction to "Diastereoselective Colloidal Self-Assembly Affects the Immunological Response of the Molecular Adjuvant Sulfavant"

artículo científico publicado en 2019

Diasteroselective Colloidal Self-Assembly Affects the Immunological Response of the Molecular Adjuvant Sulfavant

artículo científico publicado en 2019

Early Systemic Sclerosis: Serum Profiling of Factors Involved in Endothelial, T-cell, and Fibroblast Interplay is Marked by Elevated Interleukin-33 Levels

artículo científico publicado en 2014

Evidence of the transient nature of the Th17 phenotype of CD4+CD161+ T cells in the synovial fluid of patients with juvenile idiopathic arthritis

artículo científico publicado en 2011

Ex vivo lung cancer spheroids resemble treatment response of a patient with NSCLC to chemotherapy and immunotherapy: case report and translational study

scientific article published on 19 August 2019

Expression of functional tissue factor in activated T-lymphocytes in vitro and in vivo: A possible contribution of immunity to thrombosis?

artículo científico publicado en 2016

Fat: a matter of disturbance for the immune system.

artículo científico publicado en 2010

Musculin inhibits human T-helper 17 cell response to interleukin 2 by controlling STAT5B activity

artículo científico publicado en 2017

Nobiletin inhibits oxidized-LDL mediated expression of Tissue Factor in human endothelial cells through inhibition of NF-κB.

artículo científico publicado en 2016

Oxidized Low-Density Lipoproteins Induce Tissue Factor Expression in T-Lymphocytes via activation of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1

scientific article published on 27 August 2019

Perianal Crohn's disease and hidradenitis suppurativa: a possible common immunological scenario.

artículo científico publicado en 2015

Phosphatidylinositol 3-kinase (PI3Kα)/AKT axis blockade with taselisib or ipatasertib enhances the efficacy of anti-microtubule drugs in human breast cancer cells.

artículo científico publicado en 2017

Pregnancy-associated plasma protein-A promotes TF procoagulant activity in human endothelial cells by Akt-NF-κB axis.

artículo científico publicado en 2016

Primary and Acquired Resistance of Colorectal Cancer to Anti-EGFR Monoclonal Antibody Can Be Overcome by Combined Treatment of Regorafenib with Cetuximab.

artículo científico publicado en 2015

Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell lines

artículo científico publicado en 2019

Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer.

artículo científico publicado en 2017

Sphingosine Kinases promote IL-17 expression in human T lymphocytes

artículo científico publicado en 2018

Lista de obras de Giusi Barra

A New Bioassay Platform Design for the Discovery of Small Molecules with Anticancer Immunotherapeutic Activity

A new marine-derived sulfoglycolipid triggers dendritic cell activation and immune adjuvant response.

AIRE polymorphism, melanoma antigen-specific T cell immunity, and susceptibility to melanoma.

Activity and molecular targets of pioglitazone via blockade of proliferation, invasiveness and bioenergetics in human NSCLC

Antitumor activity of dual blockade of PD-L1 and MEK in NSCLC patients derived three-dimensional spheroid cultures.

Chitinase 3-like-1 is produced by human Th17 cells and correlates with the level of inflammation in juvenile idiopathic arthritis patients

Correction to "Diastereoselective Colloidal Self-Assembly Affects the Immunological Response of the Molecular Adjuvant Sulfavant"

Diasteroselective Colloidal Self-Assembly Affects the Immunological Response of the Molecular Adjuvant Sulfavant

Early Systemic Sclerosis: Serum Profiling of Factors Involved in Endothelial, T-cell, and Fibroblast Interplay is Marked by Elevated Interleukin-33 Levels

Evidence of the transient nature of the Th17 phenotype of CD4+CD161+ T cells in the synovial fluid of patients with juvenile idiopathic arthritis

Ex vivo lung cancer spheroids resemble treatment response of a patient with NSCLC to chemotherapy and immunotherapy: case report and translational study

Expression of functional tissue factor in activated T-lymphocytes in vitro and in vivo: A possible contribution of immunity to thrombosis?

Fat: a matter of disturbance for the immune system.

Musculin inhibits human T-helper 17 cell response to interleukin 2 by controlling STAT5B activity

Nobiletin inhibits oxidized-LDL mediated expression of Tissue Factor in human endothelial cells through inhibition of NF-κB.

Oxidized Low-Density Lipoproteins Induce Tissue Factor Expression in T-Lymphocytes via activation of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1

Perianal Crohn's disease and hidradenitis suppurativa: a possible common immunological scenario.

Phosphatidylinositol 3-kinase (PI3Kα)/AKT axis blockade with taselisib or ipatasertib enhances the efficacy of anti-microtubule drugs in human breast cancer cells.

Pregnancy-associated plasma protein-A promotes TF procoagulant activity in human endothelial cells by Akt-NF-κB axis.

Primary and Acquired Resistance of Colorectal Cancer to Anti-EGFR Monoclonal Antibody Can Be Overcome by Combined Treatment of Regorafenib with Cetuximab.

Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell lines

Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer.

Sphingosine Kinases promote IL-17 expression in human T lymphocytes